Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients

  • Xiol, C.
  • Vidal, S.
  • Pascual-Alonso, A.
  • Blasco, L.
  • Brandi, N.
  • Pacheco, P.
  • Gerotina, E.
  • O''Callaghan, M.
  • Pineda, M.
  • Armstrong, J.
  • Aguirre, F.J.
  • Aleu, M.
  • Alonso, X.
  • Alsius, M.
  • Amoros, M.
  • Antinolo, G.
  • Aquino, L.
  • Arellano, C.
  • Arriola, G.
  • Arteaga, R.
  • Baena, N.
  • Barcos, M.
  • Belzunces, N.
  • Boronat, S.
  • Camacho, T.
  • Campistol, J.
  • del Campo, M.
  • Campo, A.
  • Cancho, R.
  • Candau, R.
  • Canos, I.
  • Carrascosa, M.D.
  • Carratala-Marco, F.
  • Casano, J.
  • Castro, P.
  • Cobo, A.
  • Colomer, J.
  • Conejo, D.
  • Corrales, M.J.
  • Cortes, R.
  • Cruz, G.
  • Csanyi, G.
  • De Santos, M.T.
  • De Toledo, M.
  • Del Campo, M.
  • Del Toro, M.
  • Domingo, R.
  • Duat, A.
  • Duque, R.
  • Esparza, A.M.
  • Fernandez, R.
  • Fons, M.C.
  • Fontalba, A.
  • Galan, E.
  • Gallano, P.
  • Gamundi, M.J.
  • Garcia, P.L.
  • Garcia, M.D.
  • Garcia-Barcina, M.
  • Garcia-Catalan, M.J.
  • Garcia-Cazorla, A.
  • Garcia-Minaur, S.
  • Garcia-Penas, J.J.
  • Garcia-Silva, M.T.
  • Gassio, R.
  • Gean, E.
  • Gil, B.
  • Gokben, S.
  • Gonzalez, L.
  • Gonzalez, V.
  • Gonzalez, J.
  • Gonzalez, G.
  • Guillen, E.
  • Guitart, M.
  • Guitet, M.
  • Gutierrez, J.M.
  • Gutierrez, E.
  • Herranz, J.L.
  • Iglesias, G.
  • Karacic, I.
  • Lahoz, C.H.
  • Lao, J.I.
  • Lapunzina, P.
  • Lautre-Ecenarro, M.J.
  • Lluch, M.D.
  • Lopez, L.
  • Lopez-Ariztegui, A.
  • Macaya, A.
  • Marin, R.
  • Marquez, C.M.L.
  • Martin, E.
  • Martinez, B.
  • Martinez-Salcedo, E.
  • Mas, M.J.
  • Mateo, G.
  • Mendez, P.
  • Jimenez, A.M.
  • Moreno, S.
  • Mulas, F.
  • Narbona, J.
  • Nascimento, A.
  • Nieto, M.
  • Nunes, T.F.
  • Nunez, N.
  • Obon, M.
  • Onsurbe, I.
  • Ortez, C.I.
  • Orts, E.
  • Martinez, F.
  • Parrilla, R.
  • Pascual, S.I.
  • Patino, A.
  • Perez-Poyato, M.
  • Perez-Duenas, B.
  • Poo, P.
  • Puche, E.
  • Ramos, F.
  • Raspall, M.
  • Roche, A.
  • Roldan, S.
  • Rosell, J.
  • Ruiz, C.
  • Ruiz-Falco, M.L.
  • Russi, M.E.
  • Samarra, J.
  • San Antonio, V.
  • Sanchez, I.
  • Sanmartin, X.
  • Sans, A.
  • Santacana, A.
  • Scholl-Burgi, S.
  • Serrano, N.
  • Serrano, M.
  • Martin-Tamayo, P.
  • Tendero, A.
  • Torrents, J.
  • Tortosa, D.
  • Trivino, E.
  • Troncoso, L.
  • Turon, E.
  • Vazquez, P.
  • Vazquez, C.
  • Velazquez, R.
  • Ventura, C.
  • Verdu, A.
  • Vernet, A.
  • Vila, M.T.
  • Villar, C.
Rett syndrome (RTT) is a severe neurological disorder usually caused by mutations in the MECP2 gene. Since the MECP2 gene is located on the X chromosome, X chromosome inactivation (XCI) could play a role in the wide range of phenotypic variation of RTT patients; however, classical methylation-based protocols to evaluate XCI could not determine whether the preferentially inactivated X chromosome carried the mutant or the wild-type allele. Therefore, we developed an allele-specific methylation-based assay to evaluate methylation at the loci of several recurrent MECP2 mutations. We analyzed the XCI patterns in the blood of 174 RTT patients, but we did not find a clear correlation between XCI and the clinical presentation. We also compared XCI in blood and brain cortex samples of two patients and found differences between XCI patterns in these tissues. However, RTT mainly being a neurological disease complicates the establishment of a correlation between the XCI in blood and the clinical presentation of the patients. Furthermore, we analyzed MECP2 transcript levels and found differences from the expected levels according to XCI. Many factors other than XCI could affect the RTT phenotype, which in combination could influence the clinical presentation of RTT patients to a greater extent than slight variations in the XCI pattern.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients

  • Xiol, Clara
  • Vidal, Sílvia
  • Pascual-Alonso, Ainhoa
  • Blasco, Laura
  • Brandi, Núria
  • Pacheco, Paola
  • Rett Working Group
Rett syndrome; X chromosome inactivation; MECP2 gene, Síndrome de Rett; Inactivación del cromosoma X; Gen MECP2, Síndrome de Rett; Inactivació del cromosoma X; Gen MECP2, Rett syndrome (RTT) is a severe neurological disorder usually caused by mutations in the MECP2 gene. Since the MECP2 gene is located on the X chromosome, X chromosome inactivation (XCI) could play a role in the wide range of phenotypic variation of RTT patients; however, classical methylation-based protocols to evaluate XCI could not determine whether the preferentially inactivated X chromosome carried the mutant or the wild-type allele. Therefore, we developed an allele-specific methylation-based assay to evaluate methylation at the loci of several recurrent MECP2 mutations. We analyzed the XCI patterns in the blood of 174 RTT patients, but we did not find a clear correlation between XCI and the clinical presentation. We also compared XCI in blood and brain cortex samples of two patients and found differences between XCI patterns in these tissues. However, RTT mainly being a neurological disease complicates the establishment of a correlation between the XCI in blood and the clinical presentation of the patients. Furthermore, we analyzed MECP2 transcript levels and found differences from the expected levels according to XCI. Many factors other than XCI could affect the RTT phenotype, which in combination could influence the clinical presentation of RTT patients to a greater extent than slight variations in the XCI pattern., The work was supported by grants from the Spanish Ministry of Health (Instituto de Salud Carlos III/FEDER, PI15/01159); Crowdfunding program PRECIPITA, from the Spanish Ministry of Health (Fundacion Espanola para la Ciencia y la Tecnologia); the Catalan Association for Rett Syndrome; Fondobiorett and Mi Princesa Rett.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome

  • Siqueira, E|||0000-0002-8838-2570
  • Obiols-Guardia, Aida|||0000-0002-2548-8597
  • Jorge-Torres, Olga Caridad|||0000-0002-1219-8865
  • Oliveira-Mateos, Cristina|||0000-0003-2574-7816
  • Soler, M.
  • Ramesh-Kumar, Deepthi|||0000-0002-8987-2213
  • Setién, F.
  • van Rossum, D.
  • Pascual-Alonso, A.
  • Xiol, C.
  • Ivan, C.
  • Shimizu, M.
  • Armstrong, Judith|||0000-0003-0588-9307
  • Calin, George A
  • Pasterkamp, R. Jeroen|||0000-0003-1631-6440
  • Esteller, M.|||0000-0003-4490-6093
  • Guil, Sonia|||0000-0002-2257-3331
Noncoding RNAs play regulatory roles in physiopathology, but their involvement in neurodevelopmental diseases is poorly understood. Rett syndrome is a severe, progressive neurodevelopmental disorder linked to loss-of-function mutations of the MeCP2 gene for which no cure is yet available. Analysis of the noncoding RNA profile corresponding to the brain-abundant circular RNA (circRNA) and transcribed-ultraconserved region (T-UCR) populations in a mouse model of the disease reveals widespread dysregulation and enrichment in glutamatergic excitatory signaling and microtubule cytoskeleton pathways of the corresponding host genes. Proteomic analysis of hippocampal samples from affected individuals confirms abnormal levels of several cytoskeleton-related proteins together with key alterations in neurotransmission. Importantly, the glutamate receptor GRIA3 gene displays altered biogenesis in affected individuals and in vitro human cells and is influenced by expression of two ultraconserved RNAs. We also describe post-transcriptional regulation of SIRT2 by circRNAs, which modulates acetylation and total protein levels of GluR-1. As a consequence, both regulatory mechanisms converge on the biogenesis of AMPA receptors, with an effect on neuronal differentiation. In both cases, the noncoding RNAs antagonize MeCP2-directed regulation. Our findings indicate that noncoding transcripts may contribute to key alterations in Rett syndrome and are not only useful tools for revealing dysregulated processes but also molecules of biomarker value.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients

  • Xiol, Clara|||0000-0001-7013-554X
  • Vidal, Silvia|||0000-0002-3909-6682
  • Pascual-Alonso, Ainhoa|||0000-0001-7572-8563
  • Blasco-Pérez, Laura|||0000-0001-6483-5742
  • Brandi Tarrau, Núria Mercedes|||0000-0002-7853-8850
  • Pacheco, Paola
  • Gerotina, Edgar
  • O'Callaghan, Maria del Mar|||0000-0002-1896-1622
  • Pineda, Mercè|||0000-0002-6817-9807
  • Armstrong, Judith|||0000-0003-0588-9307
  • Aguirre, Francisco Javier
  • Aleu, Montserrat
  • Alonso, Xenia
  • Alsius, Mercè
  • Amorós, Maria Inmaculada
  • Antiñolo Gil, Guillermo|||0000-0002-2113-074X
  • Aquino, Lourdes
  • Arellano, Carmen
  • Arriola, Gema
  • Arteaga, Rosa
  • Baena Díez, Neus|||0000-0003-0677-240X
  • Barcos, Montserrat
  • Belzunces, Nuria
  • Boronat Guerrero, Susana|||0000-0001-7096-5578
  • Camacho, Tomás
  • Campistol, Jaume
  • del Campo Casanelles, Miguel|||0000-0001-7234-6519
  • Campo, Andrea
  • Cancho, Ramon
  • Candau, Ramon
  • Canós, Ignacio
  • Carrascosa, María del Carmen|||0000-0001-8378-117X
  • Carratalá-Marco, Francisco
  • Casano, Jovaní
  • Castro Rebollo, Pedro|||0000-0002-6118-8970
  • Cobo, Ana
  • Colomer, Jaume
  • Conejo, David
  • Corrales, Maria José
  • Cortés, Rocío
  • Cruz, Gabriel
  • Csányi, Gábor
  • Santos, María Teresa de
  • Toledo, María de
  • Del Toro, Mireia|||0000-0002-8163-1853
  • Domingo, Rosario
  • Duat, Anna
  • Duque, Rosario
  • Esparza, Ana María
  • Fernández, Rosa
  • Fons, Maria Carme
  • Fontalba, Ana
  • Galán, Enrique
  • Gallano, Pia|||0000-0001-8104-2197
  • Gamundi, María José
  • García, Pedro Luis
  • García, María del Mar
  • García-Barcina, María
  • Garcia-Catalan, María Jesús
  • García-Cazorla, Angels|||0000-0001-9853-688X
  • García-Miñaúr, Sixto
  • Garcia-Peñas, Juan Jose
  • García-Silva, María Teresa
  • Gassio, Rosa
  • Geán, Esther
  • Gil, Belén
  • Gökben, Sarenur
  • Gonzalez, Luis
  • Gonzalez, Veronica
  • Gonzalez, Julieta
  • González, Gloria
  • Guillén, Encarna
  • Guitart, Míriam|||0000-0001-5438-8782
  • Guitet, Montserrat
  • Gutierrez, Juan Manuel
  • Gutiérrez, Eva
  • Herranz, Jose Luís
  • Iglesias, Gemma
  • Karacic, Iva
  • Lahoz, Carlos H.
  • Lao, José Ignacio
  • Lapunzina, Pablo|||0000-0002-6324-4825
  • Lautre-Ecenarro, María Jesús
  • Lluch, María Dolores
  • López López, Laura|||0000-0002-8653-6206
  • López-Ariztegui, Asunción
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Marín, Rosario
  • Marquez, Charles M. Lourenço
  • Martín, Elena
  • Martínez Menéndez, Beatriz|||0000-0002-2966-2599
  • Martínez-Salcedo, Eduardo
  • Mas, María José
  • Mateo, Gonzalo
  • Mendez, Pilar
  • Jimenez, Amparo Morant
  • Moreno, Sira
  • Mulas, Fernando
  • Narbona, Juan
  • Nascimento, Andrés
  • Nieto, Manuel
  • Nunes, Tania Fabiola
  • Núñez, Núria
  • Obón, María
  • Onsurbe, Ignacio
  • Ortez González, Carlos Ignacio|||0000-0001-8187-8103
  • Orts, Emilio
  • Martinez, Francisco
  • Parrilla, Rafael
  • Pascual Pascual, Samuel Ignacio|||0000-0002-5428-8121
  • Patiño, Ana
  • Pérez-Poyato, Maria
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • Póo, Pilar
  • Puche, Eliodoro
  • Ramos, Feliciano
  • Raspall-Chaure, Miquel|||0000-0002-3132-3342
  • Roche, Ana
  • Roldan, Susana
  • Rosell Andreo, Jordi
  • Ruiz, Cesar
  • Ruiz-Falcó, María Luz
  • Russi Delfraro, María Eugenia|||0000-0003-0673-1069
  • Samarra, Jordi
  • Antonio, Victoria San
  • Sanchez, Ivan
  • Sanmartin, Xavier
  • Sans, Ana
  • Santacana, Alfredo
  • Scholl-Bürgi, Sabine|||0000-0002-2529-4231
  • Serrano, Nuria
  • Serrano, Mercedes|||0000-0002-2056-2428
  • Martin-Tamayo, Pilar
  • Tendero, Adrián
  • Torrents, Jaime
  • Tortosa, Diego
  • Triviño, Emma
  • Troncoso, Ledia
  • Turon Viñas, Eulalia|||0000-0001-6171-0282
  • Vázquez, Pilar
  • Vázquez, Carlos
  • Velázquez Fragua, Ramón
  • Ventura, Clara
  • Verdú, Alfonso
  • Vernet, Anna
  • Tomás Vila, Miguel|||0000-0002-8632-3593
  • Villar, Cristina
Rett syndrome (RTT) is a severe neurological disorder usually caused by mutations in the MECP2 gene. Since the MECP2 gene is located on the X chromosome, X chromosome inactivation (XCI) could play a role in the wide range of phenotypic variation of RTT patients; however, classical methylation-based protocols to evaluate XCI could not determine whether the preferentially inactivated X chromosome carried the mutant or the wild-type allele. Therefore, we developed an allele-specific methylation-based assay to evaluate methylation at the loci of several recurrent MECP2 mutations. We analyzed the XCI patterns in the blood of 174 RTT patients, but we did not find a clear correlation between XCI and the clinical presentation. We also compared XCI in blood and brain cortex samples of two patients and found differences between XCI patterns in these tissues. However, RTT mainly being a neurological disease complicates the establishment of a correlation between the XCI in blood and the clinical presentation of the patients. Furthermore, we analyzed MECP2 transcript levels and found differences from the expected levels according to XCI. Many factors other than XCI could affect the RTT phenotype, which in combination could influence the clinical presentation of RTT patients to a greater extent than slight variations in the XCI pattern.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients

  • Xiol, Clara
  • Vidal, Sílvia
  • Pascual-Alonso, Ainhoa
  • Blasco, Laura
  • Brandi, Núria
  • Pacheco, Paola
  • Rett Working Group
Rett syndrome; X chromosome inactivation; MECP2 gene, Síndrome de Rett; Inactivación del cromosoma X; Gen MECP2, Síndrome de Rett; Inactivació del cromosoma X; Gen MECP2, Rett syndrome (RTT) is a severe neurological disorder usually caused by mutations in the MECP2 gene. Since the MECP2 gene is located on the X chromosome, X chromosome inactivation (XCI) could play a role in the wide range of phenotypic variation of RTT patients; however, classical methylation-based protocols to evaluate XCI could not determine whether the preferentially inactivated X chromosome carried the mutant or the wild-type allele. Therefore, we developed an allele-specific methylation-based assay to evaluate methylation at the loci of several recurrent MECP2 mutations. We analyzed the XCI patterns in the blood of 174 RTT patients, but we did not find a clear correlation between XCI and the clinical presentation. We also compared XCI in blood and brain cortex samples of two patients and found differences between XCI patterns in these tissues. However, RTT mainly being a neurological disease complicates the establishment of a correlation between the XCI in blood and the clinical presentation of the patients. Furthermore, we analyzed MECP2 transcript levels and found differences from the expected levels according to XCI. Many factors other than XCI could affect the RTT phenotype, which in combination could influence the clinical presentation of RTT patients to a greater extent than slight variations in the XCI pattern., The work was supported by grants from the Spanish Ministry of Health (Instituto de Salud Carlos III/FEDER, PI15/01159); Crowdfunding program PRECIPITA, from the Spanish Ministry of Health (Fundacion Espanola para la Ciencia y la Tecnologia); the Catalan Association for Rett Syndrome; Fondobiorett and Mi Princesa Rett.